AAAAAA

   
Results: 1-18 |
Results: 18
SYSTEMIC BIAS OF CYTOKINE PRODUCTION TOWARD CELL-MEDIATED IMMUNE REGULATION IN IDDM AND TOWARD HUMORAL IMMUNITY IN GRAVES-DISEASE
Authors: KALLMANN BA HUTHER M TUBES M FELDKAMP J BERTRAMS J GRIES FA LAMPETER EF KOLB H
Citation: Ba. Kallmann et al., SYSTEMIC BIAS OF CYTOKINE PRODUCTION TOWARD CELL-MEDIATED IMMUNE REGULATION IN IDDM AND TOWARD HUMORAL IMMUNITY IN GRAVES-DISEASE, Diabetes, 46(2), 1997, pp. 237-243
CIRCULATING FORMS OF ICAM-3 (CICAM-3) - ELEVATED LEVELS IN AUTOIMMUNE-DISEASES AND LACK OF ASSOCIATION WITH CICAM-1
Authors: MARTIN S RIECKMANN P MELCHERS I WAGNER R BERTRAMS J VOSKUYL AE ROEP BO ZIELASEK J HEIDENTHAL E WEICHSELBRAUN I GALLATIN WM KOLB H
Citation: S. Martin et al., CIRCULATING FORMS OF ICAM-3 (CICAM-3) - ELEVATED LEVELS IN AUTOIMMUNE-DISEASES AND LACK OF ASSOCIATION WITH CICAM-1, The Journal of immunology, 154(4), 1995, pp. 1951-1955
INTRAGASTRIC ACIDITY AS A PREDICTOR OF THE SUCCESS OF HELICOBACTER-PYLORI ERADICATION - A STUDY IN PEPTIC-ULCER PATIENTS WITH OMEPRAZOLE AND AMOXICILLIN
Authors: LABENZ J STOLTE M BLUM AL JORIAS I LEVERKUS F SOLLBOHMER M BERTRAMS J BORSCH G
Citation: J. Labenz et al., INTRAGASTRIC ACIDITY AS A PREDICTOR OF THE SUCCESS OF HELICOBACTER-PYLORI ERADICATION - A STUDY IN PEPTIC-ULCER PATIENTS WITH OMEPRAZOLE AND AMOXICILLIN, Gut, 37(1), 1995, pp. 39-43
HIGH-DOSE OMEPRAZOLE PLUS AMOXICILLIN OR CLARITHROMYCIN CURES HELICOBACTER-PYLORI INFECTION IN DUODENAL-ULCER DISEASE
Authors: LABENZ J STOLTE M DOMIAN C BERTRAMS J BORSCH G
Citation: J. Labenz et al., HIGH-DOSE OMEPRAZOLE PLUS AMOXICILLIN OR CLARITHROMYCIN CURES HELICOBACTER-PYLORI INFECTION IN DUODENAL-ULCER DISEASE, Digestion, 56(1), 1995, pp. 14-20
AUTOANTIBODIES TO THE ISLET ANTIGEN ICA-69 OCCUR IN IDDM AND IN RHEUMATOID-ARTHRITIS
Authors: MARTIN S KARDORF J SCHULTE B LAMPETER EF GRIES FA MELCHERS I WAGNER R BERTRAMS J ROEP BO PFUTZNER A PIETROPAOLO M KOLB H
Citation: S. Martin et al., AUTOANTIBODIES TO THE ISLET ANTIGEN ICA-69 OCCUR IN IDDM AND IN RHEUMATOID-ARTHRITIS, Diabetologia, 38(3), 1995, pp. 351-355
CLINICAL COURSE OF DUODENAL-ULCER DISEASE ONE-YEAR AFTER OMEPRAZOLE PLUS AMOXICILLIN OR TRIPLE THERAPY PLUS RANITIDINE FOR CURE OF HELICOBACTER-PYLORI INFECTION
Authors: LABENZ J RUHL GH BERTRAMS J BORSCH G
Citation: J. Labenz et al., CLINICAL COURSE OF DUODENAL-ULCER DISEASE ONE-YEAR AFTER OMEPRAZOLE PLUS AMOXICILLIN OR TRIPLE THERAPY PLUS RANITIDINE FOR CURE OF HELICOBACTER-PYLORI INFECTION, European journal of gastroenterology & hepatology, 6(4), 1994, pp. 293-297
EFFECTIVE TREATMENT AFTER FAILURE OF OMEPRAZOLE PLUS AMOXICILLIN TO ERADICATE HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER DISEASE
Authors: LABENZ J RUHL GH BERTRAMS J BORSCH G
Citation: J. Labenz et al., EFFECTIVE TREATMENT AFTER FAILURE OF OMEPRAZOLE PLUS AMOXICILLIN TO ERADICATE HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER DISEASE, Alimentary pharmacology & therapeutics, 8(3), 1994, pp. 323-327
MEDIUM-DOSE AND HIGH-DOSE OMEPRAZOLE PLUS AMOXICILLIN FOR ERADICATIONOF HELICOBACTER-PYLORI IN DUODENAL-ULCER DISEASE
Authors: LABENZ J RUHL GH BERTRAMS J BORSCH G
Citation: J. Labenz et al., MEDIUM-DOSE AND HIGH-DOSE OMEPRAZOLE PLUS AMOXICILLIN FOR ERADICATIONOF HELICOBACTER-PYLORI IN DUODENAL-ULCER DISEASE, Digestive diseases and sciences, 39(7), 1994, pp. 1483-1487
LINEAR LOSS OF INSULIN SECRETORY CAPACITY DURING THE LAST 6 MONTHS PRECEDING IDDM - NO EFFECT OF ANTIEDEMATOUS THERAPY WITH KETOTIFEN
Authors: BOHMER KP KOLB H KUGLIN B ZIELASEK J HUBINGER A LAMPETER EF WEBER B KOLBBACHOFEN V JASTRAM HU BERTRAMS J GRIES FA
Citation: Kp. Bohmer et al., LINEAR LOSS OF INSULIN SECRETORY CAPACITY DURING THE LAST 6 MONTHS PRECEDING IDDM - NO EFFECT OF ANTIEDEMATOUS THERAPY WITH KETOTIFEN, Diabetes care, 17(2), 1994, pp. 138-141
MEDIUM-TERM CLINICAL COURSE OF DUODENAL-ULCER DISEASE AFTER OMEPRAZOLE AMOXICILLIN OR TRIPLE THERAPY PLUS RANITIDINE FOR CURE OF HELICOBACTER-PYLORI INFECTION
Authors: LABENZ J RUHL GH BERTRAMS J SOLLBOHMER M TILLENBURG B BORSCH G
Citation: J. Labenz et al., MEDIUM-TERM CLINICAL COURSE OF DUODENAL-ULCER DISEASE AFTER OMEPRAZOLE AMOXICILLIN OR TRIPLE THERAPY PLUS RANITIDINE FOR CURE OF HELICOBACTER-PYLORI INFECTION, Gastroenterology, 106(4), 1994, pp. 10000114-10000114
RETREATMENT AFTER FAILURE OF OMEPRAZOLE PLUS AMOXICILLIN TO CURE HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER DISEASE
Authors: LABENZ J RUHL GH BERTRAMS J SOLLBOHMER M TILLENBURG B BORSCH G
Citation: J. Labenz et al., RETREATMENT AFTER FAILURE OF OMEPRAZOLE PLUS AMOXICILLIN TO CURE HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER DISEASE, Gastroenterology, 106(4), 1994, pp. 10000115-10000115
INFLAMMATORY ISLET DAMAGE IN PATIENTS BEARING HLA-DR 3-HAPLOTYPE AND OR DR 4-HAPLOTYPE DOES NOT LEAD TO ISLET AUTOIMMUNITY/
Authors: LAMPETER EF SEIFERT I LOHMANN D HEISE JW BERTRAMS J CHRISTIE MR KOLBBACHOFEN V KOLB H
Citation: Ef. Lampeter et al., INFLAMMATORY ISLET DAMAGE IN PATIENTS BEARING HLA-DR 3-HAPLOTYPE AND OR DR 4-HAPLOTYPE DOES NOT LEAD TO ISLET AUTOIMMUNITY/, Diabetologia, 37(5), 1994, pp. 471-475
MEDIUM-DOSE OR HIGH-DOSE OMEPRAZOLE PLUS AMOXICILLIN ERADICATES HELICOBACTER-PYLORI IN GASTRIC-ULCER DISEASE
Authors: LABENZ J RUHL GH BERTRAMS J BORSCH G
Citation: J. Labenz et al., MEDIUM-DOSE OR HIGH-DOSE OMEPRAZOLE PLUS AMOXICILLIN ERADICATES HELICOBACTER-PYLORI IN GASTRIC-ULCER DISEASE, The American journal of gastroenterology, 89(5), 1994, pp. 726-730
NOMENCLATURE FOR HUMAN-COMPLEMENT FACTOR-B
Authors: KAZATCHKINE MD GESERICK G ABBAL M ALPER CA BERTRAMS J DUTOIT E HAUPTMANN G LOKKI ML MAUFF G NAKAMURA S SEGURADO OG SIEMENS I SUZUKI K WEIDINGER S
Citation: Md. Kazatchkine et al., NOMENCLATURE FOR HUMAN-COMPLEMENT FACTOR-B, European journal of immunogenetics, 20(4), 1993, pp. 307-309
TRANSFER OF INSULIN-DEPENDENT DIABETES BETWEEN HLA-IDENTICAL SIBLINGSBY BONE-MARROW TRANSPLANTATION
Authors: LAMPETER EF HOMBERG M QUABECK K SCHAEFER UW WERNET P BERTRAMS J GROSSEWILDE H GRIES FA KOLB H
Citation: Ef. Lampeter et al., TRANSFER OF INSULIN-DEPENDENT DIABETES BETWEEN HLA-IDENTICAL SIBLINGSBY BONE-MARROW TRANSPLANTATION, Lancet, 341(8855), 1993, pp. 1243-1244
QUALITATIVE AND SEMIQUANTITATIVE INVASIVE AND NONINVASIVE ASSESSMENT OF HELICOBACTER-PYLORI COLONIZATION OF THE GASTRIC-MUCOSA
Authors: LABENZ J STOLTE M AYGEN S HENNEMANN O BERTRAMS J BORSCH G
Citation: J. Labenz et al., QUALITATIVE AND SEMIQUANTITATIVE INVASIVE AND NONINVASIVE ASSESSMENT OF HELICOBACTER-PYLORI COLONIZATION OF THE GASTRIC-MUCOSA, Zeitschrift fur Gastroenterologie, 31(7-8), 1993, pp. 437-443
IMMUNOLOGICAL STANDARDIZATION - NOMENCLATURE FOR HUMAN-COMPLEMENT FACTOR-B (REPRINTED FROM BULL WHO, VOL 70, PG 541-543, 1992)
Authors: KAZATCHKINE MD GESERICK G ABBAL M ALPER CA BERTRAMS J DUTOIT E HAUPTMANN G LOKKI ML MAUFF G NAKAMURA S SEGURADO OG SIEMENS I SUZUKI K WEIDINGER S
Citation: Md. Kazatchkine et al., IMMUNOLOGICAL STANDARDIZATION - NOMENCLATURE FOR HUMAN-COMPLEMENT FACTOR-B (REPRINTED FROM BULL WHO, VOL 70, PG 541-543, 1992), Journal of immunological methods, 163(1), 1993, pp. 9-11
MATERNAL HLA-IMPRINTING IN IDDM FAMILIES
Authors: SEUCHTER SA KNAPP M PELSTER G KOLB H BERTRAMS J BAUR MP
Citation: Sa. Seuchter et al., MATERNAL HLA-IMPRINTING IN IDDM FAMILIES, American journal of human genetics, 53(3), 1993, pp. 859-859
Risultati: 1-18 |